01/15/2024

Streamlining Prior Authorizations: Optimizing Oncology Billing

Prior Authorization (PA) stands as a critical component in the realm of Oncology billing, a pivotal force in the delicate balance of providing cancer care while ensuring financial stability. A recent survey of 700 oncologists highlighted challenges, with 93 percent of patients experiencing delays in critical treatment due to PA requirements, and a notable 31 percent reporting delays exceeding four to five days. Published by various medical organizations, this survey aimed to spotlight the growing issue of Oncology Prior Authorization in medical billing services.

Originally conceived to control costs and protect patients from unexpected bills, PA has inadvertently led to administrative burdens, heightened claim denials, and care delays. These challenges adversely affect providers' financial performance and create undue stress for billing teams and patients.

Addressing the root causes of process delays, administrative complexities, and claim denials that result in write-offs is intricate, particularly with the rising PA demands from payers.

READ MORE